Current Opinion in Lipidology is a premier journal published by Lippincott Williams & Wilkins, offering critical insights into the ever-evolving landscape of lipid research. With an impressive convergence spanning from 1990 to 2024, this journal serves as an essential platform for researchers, clinicians, and professionals dedicated to the study of lipids in relation to cardiovascular health, endocrinology, and metabolism. The journal currently holds a distinguished Q1 ranking in Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, and Nutrition and Dietetics, showcasing its significant impact in these fields. Additionally, it ranks in the Q2 quartile for Cell Biology and Molecular Biology, underlining its comprehensive approach to lipidology. Though not open access, the content is rich with cutting-edge reviews, clinical studies, and expert opinions that aim to advance knowledge and practice in lipid metabolism, making it a valuable resource for anyone seeking to stay abreast of the latest developments in lipid research.

DEVELOPMENTAL CELL, published by CELL PRESS, stands as a premier journal in the fields of Biochemistry, Genetics and Molecular Biology, Cell Biology, and Developmental Biology. With a significant influence evidenced by its Q1 rankings across several categories in 2023 and a remarkable Scopus ranking placing it at the 98th percentile for Developmental Biology, this journal is pivotal for researchers and academics aiming to advance their understanding of cellular processes. Covering a broad range of topics from molecular mechanisms to cellular developmental pathways, DEVELOPMENTAL CELL publishes cutting-edge research articles that contribute to the dynamic landscape of cell biology and related disciplines. Although it does not currently offer open access, the journal is accessible through institutional subscriptions, reinforcing its commitment to disseminating high-quality scientific knowledge produced by leading experts in the field. Based in the United States, DEVELOPMENTAL CELL continues to push the boundaries of discovery and innovation in life sciences, making it an essential resource for professionals, researchers, and students alike in the quest for foundational biological insights.

Cell Reports is a prestigious open-access journal published by CELL PRESS that has firmly established itself as a leading voice in the fields of Biochemistry, Genetics, and Molecular Biology. Since its inception in 2012, the journal has provided an innovative platform for rapid dissemination of cutting-edge research, ensuring that high-quality findings are accessible to a global audience. With an impressive impact factor and ranking within the top 10% in its category, as reflected by its Q1 ranking in Scopus, Cell Reports serves a vital role in advancing scientific knowledge and fostering collaboration among researchers. The journal's commitment to the open-access model not only enhances visibility but also encourages the sharing of critical advancements in molecular biology. Situated in the Netherlands, its contributions are recognized worldwide, making Cell Reports an indispensable resource for scientists aiming to stay at the forefront of their fields and facilitate breakthroughs that may shape the future of biomedicine.

FEBS Journal is a prestigious, peer-reviewed publication dedicated to advancing the field of biochemistry, cell biology, and molecular biology. Published by WILEY in the United Kingdom, this journal boasts an impressive impact factor and ranks in the top quartile (Q1) across multiple relevant categories, including Biochemistry, Cell Biology, and Molecular Biology, reflecting its significant contribution to scientific research. With an ISSN of 1742-464X and an E-ISSN of 1742-4658, the FEBS Journal publishes original research and comprehensive reviews that push the boundaries of knowledge and innovation in the biosciences. As a vital resource for researchers, professionals, and students alike, the journal offers Open Access options, ensuring that cutting-edge discoveries are accessible to a broad audience. With a publication history converging from 2005 to the present and a robust emphasis on high-quality scholarly work, the FEBS Journal remains an essential platform for the dissemination of significant findings and advancements in the life sciences.

Progress in Lipid Research, published by Pergamon-Elsevier Science Ltd, is a leading scientific journal dedicated to advancing the understanding of lipid biology and its implications for human health. With an impressive impact factor, it ranks in the Q1 quartile in both Biochemistry and Cell Biology as of 2023, reflecting its vital role in disseminating high-quality research. Covering a wide scope of topics from lipid metabolism to cell signaling pathways, the journal serves as a key resource for researchers, professionals, and students alike, striving to elucidate the complex functions of lipids in various biological systems. With publication converging since 1978 and extending to 2024, Progress in Lipid Research continues to provide innovative insights and foster collaboration within the scientific community, solidifying its reputation as an essential platform for lipid research.

Algal Research - Biomass Biofuels and Bioproducts is a prestigious academic journal published by Elsevier, dedicated to advancing the field of algal biotechnology and its applications in biomass, biofuels, and bioproducts. With an ISSN of 2211-9264 and a notable impact factor, this journal is recognized as a leading source of innovative research, boasting a current Scopus rank of #31 out of 406 in the domain of Agricultural and Biological Sciences, specifically Agronomy and Crop Science, positioning it in the top 8% of its field (92nd percentile). This open-access publication, established in 2012 and covering literature up to 2024, prioritizes disseminating high-quality research that fosters sustainable solutions for energy and bioproducts derived from algal resources. As a Q1 ranked journal in the 2023 Agronomy and Crop Science category, it serves as a vital resource for researchers, professionals, and students seeking to understand and leverage the potential of algae within the biodiverse framework of bioeconomy and sustainable practices.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, published by Lippincott Williams & Wilkins, is a leading journal in the field of cardiovascular medicine, dedicated to the advancement of research surrounding arterial diseases, thrombosis, and vascular biology. With an impressive impact factor indicative of its reach and influence, this journal occupies a prominent position in the Q1 category of cardiology, ranking 13th out of 387 in its field according to Scopus, placing it within the top 96th percentile among cardiovascular research journals. Since its inception in 1990, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY has been pivotal in disseminating cutting-edge research that drives innovation and education in cardiovascular health. Although it does not operate under an open access model, the journal is a vital resource for researchers, clinicians, and students looking for high-quality, peer-reviewed articles that contribute to the understanding and treatment of cardiovascular and vascular disorders. Its commitment to rigorous scientific standards and its focus on impactful findings make it an essential publication for anyone dedicated to the field.

Journal of Clinical Lipidology, published by Elsevier Science Inc, is a leading platform dedicated to advancing the understanding of lipidology and its impact on cardiovascular health. With an ISSN of 1933-2874 and E-ISSN 1876-4789, this esteemed journal boasts a remarkable Q1 ranking in key medical categories, including Cardiology and Cardiovascular Medicine, Internal Medicine, and Nutrition and Dietetics, solidifying its position as a vital resource for the latest research and clinical practices. This journal not only serves as a repository for groundbreaking studies but also provides insights into complex interactions between lipid metabolism and chronic diseases, including diabetes and obesity. Researchers, practitioners, and students will find a wealth of carefully vetted articles that drive innovation and improve patient outcomes in lipid management. Although it does not currently offer open access, the Journal of Clinical Lipidology ensures high visibility through rigorous peer review and a commitment to quality, making it an essential read for anyone invested in the future of lipidology.

JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal dedicated to the study of bioenergetics and biomembranes, covering essential topics such as cellular energy transformation and membrane dynamics. Since its inception in 1976, the journal has developed a robust reputation within the scientific community, currently holding a Q3 ranking in Cell Biology and a Q2 ranking in Physiology for 2023. Boasting a prestigious Scopus Rank in both Biochemistry and Physiology, it serves as a crucial platform for disseminating pioneering research findings. With its commitment to quality and innovation, the journal plays a significant role in advancing our understanding of the fundamental processes that underlie life at the cellular level. Although it does not offer open access options, the journal remains accessible through universities and research institutions, ensuring that vital research is widely shared among scholars, professionals, and students alike. The JOURNAL OF BIOENERGETICS AND BIOMEMBRANES is essential for anyone seeking to contribute to or stay informed about developments in this dynamic field.

PROSTAGLANDINS & OTHER LIPID MEDIATORS, published by Elsevier Science Inc, is a leading journal dedicated to the advancements in the field of lipid mediators, with a specific focus on prostaglandins and other bioactive lipids. This journal, indexed under ISSN 1098-8823 and E-ISSN 2212-196X, serves as a crucial platform for researchers and professionals to disseminate significant findings that span multiple disciplines, including Biochemistry, Cell Biology, Pharmacology, and Physiology. In the 2023 category quartiles, it has achieved commendable positions such as Q2 in Biochemistry and Q2 in Physiology, underscoring its importance and influence in these domains. Although it is not an open-access journal, it provides robust access options, enhancing the visibility of vital research. With its establishment in 1996, the journal continues its commitment to fostering innovative research until 2024, making it an essential resource for those involved in the dynamic realms of lipid biology and medical research.